| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Senior Vice President
1 company
Carl Walkey last filed a Form 4 in August 2022, as Senior Vice President at NGNE. Carl Walkey's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Carl Walkey a strong insider score of 94/100, based on 19 past trades. Over a 12-month horizon, all 19 of those trades were profitable, with an average 12-month return of +87.3%.
At the last filing, the largest reported position was 1,352,489 shares of NGNE. The NGNE filings lean toward selling, a net 34,850 shares.
Carl Walkey has 28 Form 4 filings on record from January 2021 to August 2022, all as Senior Vice President at Neurogene (NGNE), 2021–2022.
The 30 reported transactions were 26 open-market sales and 4 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 24 sales worth about $426K.
The largest open-market sale was 3,000 shares of NGNE at an average $14.20 on February 10, 2021, about $43K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 600 | $10.19 | $6,114.00 | - | -23.3% | -90.3% | |
| Jun 9, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 650 | $10.82 | $7,035.99 | - | -27.4% | -90.2% | |
| Jun 8, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 600 | $11.00 | $6,600.00 | - | -29.7% | -89.8% | |
| Jun 4, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 600 | $10.00 | $6,000.00 | - | -21.5% | -90.2% | |
| May 26, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 600 | $10.00 | $6,000.00 | - | -39.1% | -89.8% | |
| May 19, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 600 | $10.63 | $6,378.00 | - | -35.3% | -89.4% | |
| May 12, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 1,200 | $11.09 | $13,308.00 | - | -33.6% | -90.0% | |
| May 5, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 1,200 | $11.30 | $13,560.00 | - | -40.0% | -88.4% | |
| Apr 28, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 2,400 | $12.58 | $30,192.00 | -0.2% | -43.7% | -90.3% | |
| Apr 26, 2021 | NGNE Neurogene Inc. | Senior Vice President | Sell | 600 | $13.00 | $7,800.00 | - | -41.3% | -90.1% |